Clinical Trial Update: Stereotactic Ablative Radiotherapy (SABR) for Low Risk Prostate Cancer With Injectable Rectal Spacer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating stereotactic ablative radiotherapy (SABR) for low risk prostate cancer using an injectable rectal spacer; study status completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• SAbR (stereotactic ablative radiotherapy)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-05-07